They found that microRNAs; miR-200b-3p and miR-429–5p suppress proliferation, migration, and invasion in TNBC cell lines, via inactivation of the LIMK1/CFL1 pathway, therefore acting as tumour suppressors, and suggesting that blocking this pathway has a potential therapeutic benefit when treating TNBC. This evidence concerns the gene CFL1 and neoplasm.